vs
Concrete Pumping Holdings, Inc.（BBCP）与MESA LABORATORIES INC（MLAB）财务数据对比。点击上方公司名可切换其他公司
Concrete Pumping Holdings, Inc.的季度营收约是MESA LABORATORIES INC的1.5倍（$98.9M vs $65.1M），MESA LABORATORIES INC净利率更高（5.6% vs 5.4%，领先0.2%），MESA LABORATORIES INC同比增速更快（3.6% vs -3.2%），MESA LABORATORIES INC自由现金流更多（$18.0M vs $1.9M），过去两年MESA LABORATORIES INC的营收复合增速更高（5.1% vs 4.8%）
Concrete Pumping Holdings, Inc.是领先的混凝土泵送服务及相关设备租赁供应商，主要面向美国和英国市场，业务覆盖基础设施建设、商业地产开发、住宅建造等核心建筑领域，为各类项目提供高效安全的混凝土输送解决方案。
梅萨实验室有限公司开发、生产和销售专业质控、校准及监测仪器与配套服务，核心业务覆盖医疗健康、制药、食品饮料、工业卫生及环境检测领域，为全球客户满足合规及运营安全需求提供支持。
BBCP vs MLAB — 直观对比
营收规模更大
BBCP
是对方的1.5倍
$65.1M
营收增速更快
MLAB
高出6.8%
-3.2%
净利率更高
MLAB
高出0.2%
5.4%
自由现金流更多
MLAB
多$16.1M
$1.9M
两年增速更快
MLAB
近两年复合增速
4.8%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $98.9M | $65.1M |
| 净利润 | $5.3M | $3.6M |
| 毛利率 | 43.8% | 64.2% |
| 营业利润率 | 17.0% | 12.2% |
| 净利率 | 5.4% | 5.6% |
| 营收同比 | -3.2% | 3.6% |
| 净利润同比 | -43.6% | 316.6% |
| 每股收益（稀释后） | $0.09 | $0.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBCPMLAB
| Q4 25 | $98.9M | $65.1M | ||
| Q3 25 | $94.2M | $60.7M | ||
| Q2 25 | $85.2M | $59.5M | ||
| Q1 25 | $78.0M | $62.1M | ||
| Q4 24 | $102.1M | $62.8M | ||
| Q3 24 | $100.6M | $57.8M | ||
| Q2 24 | $98.7M | $58.2M | ||
| Q1 24 | $90.0M | $58.9M |
净利润BBCPMLAB
| Q4 25 | $5.3M | $3.6M | ||
| Q3 25 | $3.7M | $2.5M | ||
| Q2 25 | $-4.0K | $4.7M | ||
| Q1 25 | $-2.6M | $-7.1M | ||
| Q4 24 | $9.4M | $-1.7M | ||
| Q3 24 | $7.6M | $3.4M | ||
| Q2 24 | $3.0M | $3.4M | ||
| Q1 24 | $-3.8M | $-254.6M |
毛利率BBCPMLAB
| Q4 25 | 43.8% | 64.2% | ||
| Q3 25 | 42.9% | 61.5% | ||
| Q2 25 | 42.5% | 62.0% | ||
| Q1 25 | 40.0% | 61.8% | ||
| Q4 24 | 45.3% | 63.3% | ||
| Q3 24 | 44.3% | 61.3% | ||
| Q2 24 | 42.3% | 64.0% | ||
| Q1 24 | 37.0% | 62.1% |
营业利润率BBCPMLAB
| Q4 25 | 17.0% | 12.2% | ||
| Q3 25 | 13.7% | 7.8% | ||
| Q2 25 | 9.7% | 5.1% | ||
| Q1 25 | 4.5% | 2.4% | ||
| Q4 24 | 18.8% | 9.2% | ||
| Q3 24 | 16.5% | 6.1% | ||
| Q2 24 | 12.2% | 9.6% | ||
| Q1 24 | 1.6% | -460.6% |
净利率BBCPMLAB
| Q4 25 | 5.4% | 5.6% | ||
| Q3 25 | 3.9% | 4.1% | ||
| Q2 25 | -0.0% | 8.0% | ||
| Q1 25 | -3.4% | -11.4% | ||
| Q4 24 | 9.2% | -2.7% | ||
| Q3 24 | 7.5% | 5.9% | ||
| Q2 24 | 3.1% | 5.8% | ||
| Q1 24 | -4.3% | -432.2% |
每股收益（稀释后）BBCPMLAB
| Q4 25 | $0.09 | $0.65 | ||
| Q3 25 | $0.07 | $0.45 | ||
| Q2 25 | $-0.01 | $0.85 | ||
| Q1 25 | $-0.06 | $-1.30 | ||
| Q4 24 | $0.16 | $-0.31 | ||
| Q3 24 | $0.13 | $0.63 | ||
| Q2 24 | $0.05 | $0.62 | ||
| Q1 24 | $-0.08 | $-47.26 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $44.4M | $29.0M |
| 总债务越低越好 | $417.9M | $68.4M |
| 股东权益账面价值 | $264.8M | $186.7M |
| 总资产 | $879.5M | $434.8M |
| 负债/权益比越低杠杆越低 | 1.58× | 0.37× |
8季度趋势，按日历期对齐
现金及短期投资BBCPMLAB
| Q4 25 | $44.4M | $29.0M | ||
| Q3 25 | $41.0M | $20.4M | ||
| Q2 25 | $37.8M | $21.3M | ||
| Q1 25 | $85.1M | $27.3M | ||
| Q4 24 | $43.0M | $27.3M | ||
| Q3 24 | $26.3M | $24.3M | ||
| Q2 24 | $18.0M | $28.5M | ||
| Q1 24 | $14.7M | $28.2M |
总债务BBCPMLAB
| Q4 25 | $417.9M | $68.4M | ||
| Q3 25 | $417.6M | $69.4M | ||
| Q2 25 | $417.3M | $70.3M | ||
| Q1 25 | $417.1M | $71.3M | ||
| Q4 24 | $373.3M | $72.2M | ||
| Q3 24 | $372.9M | $73.1M | ||
| Q2 24 | $372.6M | $74.1M | ||
| Q1 24 | $372.2M | — |
股东权益BBCPMLAB
| Q4 25 | $264.8M | $186.7M | ||
| Q3 25 | $261.3M | $178.5M | ||
| Q2 25 | $261.8M | $172.5M | ||
| Q1 25 | $260.7M | $159.8M | ||
| Q4 24 | $321.7M | $155.2M | ||
| Q3 24 | $314.7M | $161.5M | ||
| Q2 24 | $308.3M | $150.7M | ||
| Q1 24 | $307.9M | $145.4M |
总资产BBCPMLAB
| Q4 25 | $879.5M | $434.8M | ||
| Q3 25 | $886.0M | $430.4M | ||
| Q2 25 | $878.8M | $435.7M | ||
| Q1 25 | $912.9M | $433.3M | ||
| Q4 24 | $898.0M | $433.3M | ||
| Q3 24 | $890.8M | $454.1M | ||
| Q2 24 | $894.7M | $440.4M | ||
| Q1 24 | $894.8M | $446.8M |
负债/权益比BBCPMLAB
| Q4 25 | 1.58× | 0.37× | ||
| Q3 25 | 1.60× | 0.39× | ||
| Q2 25 | 1.59× | 0.41× | ||
| Q1 25 | 1.60× | 0.45× | ||
| Q4 24 | 1.16× | 0.47× | ||
| Q3 24 | 1.19× | 0.45× | ||
| Q2 24 | 1.21× | 0.49× | ||
| Q1 24 | 1.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.5M | $18.8M |
| 自由现金流经营现金流 - 资本支出 | $1.9M | $18.0M |
| 自由现金流率自由现金流/营收 | 1.9% | 27.7% |
| 资本支出强度资本支出/营收 | 12.7% | 1.1% |
| 现金转化率经营现金流/净利润 | 2.72× | 5.17× |
| 过去12个月自由现金流最近4个季度 | $17.5M | $37.9M |
8季度趋势，按日历期对齐
经营现金流BBCPMLAB
| Q4 25 | $14.5M | $18.8M | ||
| Q3 25 | $19.1M | $8.2M | ||
| Q2 25 | $24.7M | $1.9M | ||
| Q1 25 | $6.0M | $12.7M | ||
| Q4 24 | $22.4M | $18.1M | ||
| Q3 24 | $35.0M | $5.3M | ||
| Q2 24 | $9.1M | $10.7M | ||
| Q1 24 | $20.3M | $12.9M |
自由现金流BBCPMLAB
| Q4 25 | $1.9M | $18.0M | ||
| Q3 25 | $4.3M | $7.1M | ||
| Q2 25 | $11.1M | $884.0K | ||
| Q1 25 | $191.0K | $11.9M | ||
| Q4 24 | $16.1M | $17.3M | ||
| Q3 24 | $26.4M | $3.5M | ||
| Q2 24 | $-1.9M | $9.9M | ||
| Q1 24 | $2.5M | $12.3M |
自由现金流率BBCPMLAB
| Q4 25 | 1.9% | 27.7% | ||
| Q3 25 | 4.6% | 11.7% | ||
| Q2 25 | 13.0% | 1.5% | ||
| Q1 25 | 0.2% | 19.2% | ||
| Q4 24 | 15.8% | 27.6% | ||
| Q3 24 | 26.2% | 6.0% | ||
| Q2 24 | -1.9% | 16.9% | ||
| Q1 24 | 2.8% | 21.0% |
资本支出强度BBCPMLAB
| Q4 25 | 12.7% | 1.1% | ||
| Q3 25 | 15.7% | 1.8% | ||
| Q2 25 | 16.0% | 1.7% | ||
| Q1 25 | 7.5% | 1.2% | ||
| Q4 24 | 6.2% | 1.3% | ||
| Q3 24 | 8.6% | 3.1% | ||
| Q2 24 | 11.2% | 1.5% | ||
| Q1 24 | 19.7% | 0.9% |
现金转化率BBCPMLAB
| Q4 25 | 2.72× | 5.17× | ||
| Q3 25 | 5.16× | 3.32× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.38× | — | ||
| Q3 24 | 4.63× | 1.54× | ||
| Q2 24 | 3.00× | 3.17× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBCP
| US Concrete Pumping | $72.2M | 73% |
| US Concrete Waste Management Services | $21.3M | 22% |
| Other | $5.4M | 5% |
MLAB
| Sterilization And Disinfection Control | $24.9M | 38% |
| Biopharmaceutical Development | $14.4M | 22% |
| Other | $14.1M | 22% |
| Clinical Genomics | $11.8M | 18% |
